Warburg Pincus nears $7 billion deal for PANTHERx Rare

Corporate Action
โดย Reuters·Read original
Summary · why it matters

Private equity firm Warburg Pincus is nearing a deal to acquire specialty pharmacy company PANTHERx Rare for more than $7 billion, including debt, the Wall Street Journal reported, citing people familiar with the matter. Warburg is partnering with Abu Dhabi Investment Authority on the acquisition. A deal could come together soon, the sources said, but cautioned that nothing is finalized and the timing could still slip. Pittsburgh-based PANTHERx specializes in providing medicines and patient support services for rare and orphan diseases and is owned by an investor group that includes private equity firm General Atlantic.

Impact on stocks 1

Health Care▲ · 1 stocks

Off-coverage companies 4

PANTHERx RarePrivate▲ Positive
Capitalrelevance

PANTHERx Rare is being acquired for over $7 billion

Warburg PincusPrivate▲ Positive
Capitalrelevance

Warburg Pincus is the lead acquirer in the $7 billion deal for PANTHERx Rare

Abu Dhabi Investment AuthorityPrivate▲ Positive
Capitalrelevance

Abu Dhabi Investment Authority is partnering with Warburg on the acquisition

General AtlanticPrivate▼ Negative
Capitalrelevance

General Atlantic is the current owner selling PANTHERx Rare

© 2026 MarketDXNews